ライフサイエンスコーパス: revolutionize the treatment

1 ombination anti-retroviral therapy (ART) has revolutionized the treatment and prevention of HIV-1 inf

2 Imatinib has revolutionized the treatment for adult CML by eliminatin

3 The introduction of levodopa revolutionized the treatment for this disorder, but the

4 nological and inflammatory pathways and help revolutionize the treatment landscape for schizophrenia.

5 uton's tyrosine kinase (BTK) inhibitors have revolutionized the treatment landscape for B cell lympho

6 chimeric antigen receptor (CAR) T cells has revolutionized the treatment landscape for hematologic m

7 Immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape for non-small cel

8 P-ribose) polymerase inhibitors (PARPi) have revolutionized the treatment landscape for patients suff

9 ic antigen receptor (CAR) T-cell therapy has revolutionized the treatment landscape for relapsed/refr

10 While transcatheter interventions have revolutionized the treatment landscape in cardiology, po

11 nt inhibitors with antiangiogenic agents has revolutionized the treatment landscape of advanced hepat

12 of the BCR. The advent of BTK inhibitors has revolutionized the treatment landscape of B cell maligna

13 Cell and gene therapies are revolutionizing the treatment landscape for children and

14 ell therapies hold significant potential for revolutionizing the treatment landscape of CRC.

15 e lungs to regenerate following injury could revolutionize the treatment of a wide range of different

16 A potent rifamycin-sparing regimen could revolutionize the treatment of adults and children requi

17 ic peptide displays significant potential to revolutionize the treatment of bone fractures.

18 Gene therapy is on its way to revolutionize the treatment of both inherited and acquir

19 y in recent years has shown the potential to revolutionize the treatment of cancer.

20 geted liposomes (LTLs) have the potential to revolutionize the treatment of cancer.

21 nd medicinal chemistry are now converging to revolutionize the treatment of cancer.

22 cutaneous coronary intervention continues to revolutionize the treatment of coronary atherosclerosis.

23 Success will revolutionize the treatment of diabetes by providing a m

24 h which to study gene function and is set to revolutionize the treatment of disease.

25 Although CRISPR-Cas9 technology is poised to revolutionize the treatment of diseases with underlying

26 ge of second-generation therapies that could revolutionize the treatment of functional gastrointestin

27 ng and delivery technologies are expected to revolutionize the treatment of genetic disorders of visi

28 btilisin/kexin type 9 inhibitors) are set to revolutionize the treatment of hypercholesterolemia in t

29 Therapeutic mRNA has the potential to revolutionize the treatment of myriad diseases and, in 2

30 rain stimulation tools have the potential to revolutionize the treatment of neuropsychiatric disorder

31 articular signaling networks and promises to revolutionize the treatment of these diseases.

32 The use of the botulinum toxins has revolutionized the treatment of a broad array of disease

33 CAR T cell therapy has revolutionized the treatment of a spectrum of blood-rela

34 CD19-directed immunotherapies have revolutionized the treatment of advanced B-cell acute ly

35 Cancer immunotherapy has revolutionized the treatment of advanced cancers and is

36 and immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced cancers includi

37 Immune checkpoint inhibitor therapy has revolutionized the treatment of advanced malignancies in

38 inhibitors (ICIs) such as pembrolizumab have revolutionized the treatment of advanced melanoma, but m

39 Immunotherapy has revolutionized the treatment of advanced non-small-cell

40 Antiretroviral therapy has revolutionized the treatment of AIDS, turning a deadly d

41 ecombinant human erythropoietin (rHuEpo) has revolutionized the treatment of anemia, recent clinical

42 catheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis, with th

43 ranscatheter aortic valve replacement (TAVR) revolutionized the treatment of aortic stenosis.

44 mAbs have revolutionized the treatment of autoimmune disorders.

45 Immunotherapies have revolutionized the treatment of B-cell acute lymphoblast

46 antigen receptor T-cell therapy (CAR-T) has revolutionized the treatment of B-cell and other hematol

47 en receptor (CAR) T-cell (CAR-T) therapy has revolutionized the treatment of B-cell malignancies, man

48 Monoclonal antibodies (mAbs) have revolutionized the treatment of B-cell malignancies.

49 CD20 monoclonal antibody (mAb) rituximab has revolutionized the treatment of B-cell malignancies.

50 antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of B-cell malignancies; how

51 Immunotherapies have revolutionized the treatment of blood cancer.

52 BRAF/MEK inhibitors revolutionized the treatment of BRAF V600E-variant anapl

53 Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer and are now the b

54 bodies targeting coinhibitory receptors have revolutionized the treatment of cancer by inducing durab

55 s (ICIs) targeting CTLA4, PD-1 and PD-L1 has revolutionized the treatment of cancer, as recognized by

56 eutical inactivation of driver oncogenes has revolutionized the treatment of cancer, replacing cytoto

57 de, immune-checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer.

58 Immunotherapies have revolutionized the treatment of certain cancers, but cha

59 Immune-modulating therapies have revolutionized the treatment of chronic diseases, partic

60 B-cell receptor (BCR) signaling pathway have revolutionized the treatment of chronic lymphocytic leuk

61 h as venetoclax (VEN) (Bcl-2 inhibitor) have revolutionized the treatment of chronic lymphocytic leuk

62 d by the US Food and Drug Administration and revolutionized the treatment of chronic myelogenous leuk

63 Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of chronic myeloid leukemia

64 lar endothelial growth factor therapies have revolutionized the treatment of clinically significant d

65 Although TA monotherapy has revolutionized the treatment of CLL, residual disease, a

66 The introduction of azoles further revolutionized the treatment of coccidioidal infections.

67 e blockade of PD-1 or its ligand, PD-L1, has revolutionized the treatment of cSCC; however, approxima

68 spartate receptor (NMDAR) antagonist(1), has revolutionized the treatment of depression because of it

69 nd artemisinin, respectively, therapies that revolutionized the treatment of devastating parasite dis

70 Frozen Elephant Trunk has revolutionized the treatment of extensive aortic patholo

71 hibitor of KIT tyrosine kinase function have revolutionized the treatment of GIST.

72 nly a single 7-day course, is well known and revolutionized the treatment of hairy cell leukemia.

73 ose cotransporter 2 inhibitors (SGLT2i) have revolutionized the treatment of heart failure and diabet

74 receptor T-cell therapy (CAR-T therapy) has revolutionized the treatment of hematologic malignancies

75 Cellular immunotherapy has revolutionized the treatment of hematologic malignancies

76 en receptor (CAR) T-cell therapy (CAR-T) has revolutionized the treatment of hematologic malignancies

77 ic antigen receptor (CAR)-T cell therapy has revolutionized the treatment of hematologic malignancies

78 s with chimeric antigen receptors (CARs) has revolutionized the treatment of hematological malignanci

79 vir as a pharmacoenhancer for anti-HIV drugs revolutionized the treatment of HIV infection.

80 These drugs have revolutionized the treatment of human disease.

81 Highly active antiretroviral therapy has revolutionized the treatment of human immunodeficiency v

82 Immunologically targeted therapies have revolutionized the treatment of inflammatory dermatoses,

83 delivery of antibody-based therapeutics has revolutionized the treatment of intraocular vascular dis

84 ic antigen receptor (CAR) T-cell therapy has revolutionized the treatment of large B-cell lymphoma (L

85 (GVL) effect, mediated by donor T cells, has revolutionized the treatment of leukemia.

86 Small interfering RNAs (siRNAs) have revolutionized the treatment of liver diseases.

87 Cancer immunotherapy has revolutionized the treatment of lung adenocarcinoma (LUA

88 The advent of molecular profiling has revolutionized the treatment of lung cancer by comprehen

89 vent of intracytoplasmic sperm injection has revolutionized the treatment of male infertility and off

90 of IVF and intracytoplasmic sperm injection revolutionized the treatment of male infertility by requ

91 Small molecules and antibodies have revolutionized the treatment of malignant diseases and a

92 herapies, especially kinase inhibitors, have revolutionized the treatment of many cancers and have dr

93 Immune checkpoint blockade (ICB) has revolutionized the treatment of many cancers by leveragi

94 past decade, the field of immunotherapy has revolutionized the treatment of many cancers with the de

95 hat act against these driver alterations has revolutionized the treatment of many human cancers.

96 apy with anti-CTLA-4 and anti-PD-1/PD-L1 has revolutionized the treatment of many solid tumors.

97 Immunotherapy has revolutionized the treatment of many tumors.

98 nconjugated monoclonal antibodies (mAb) have revolutionized the treatment of many types of cancer.

99 In recent years, ketamine has revolutionized the treatment of MDD, with its rapid anti

100 ymphocyte-associated protein 4 (CTLA-4) have revolutionized the treatment of melanoma patients.

101 al antipsychotic (AAP) medications that have revolutionized the treatment of mental illness have beco

102 Immune checkpoint blockade therapy has revolutionized the treatment of metastatic and solid tum

103 Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of metastatic clear cell re

104 Several new classes of agents have revolutionized the treatment of metastatic melanoma, all

105 stemically delivered targeted biologics have revolutionized the treatment of moderate-to-severe psori

106 omponent of a new oral drug regimen that has revolutionized the treatment of multidrug-resistant tube

107 l successes achieved with immunotherapy have revolutionized the treatment of multiple advanced-stage

108 Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of multiple cancer types.

109 Advances in immunotherapy have revolutionized the treatment of multiple cancers.

110 al of various CAR-T therapies and BsAbs have revolutionized the treatment of multiple hematological m

111 Immune checkpoint blockade has revolutionized the treatment of multiple tumor types, in

112 hus, the development of VEGF antagonists has revolutionized the treatment of nAMD, diabetic retinopat

113 Its use has revolutionized the treatment of nematode and arthropod p

114 Anti-VEGF drugs have also revolutionized the treatment of neovascular eye disorder

115 Immune checkpoint blockers (ICBs) have revolutionized the treatment of non-small cell lung canc

116 argeting somatically activated oncogenes has revolutionized the treatment of non-small cell lung canc

117 Immunotherapy has revolutionized the treatment of patients with cancer.

118 nt (C) inhibition into clinical practice has revolutionized the treatment of patients with complement

119 te-ribose) polymerase (PARP) inhibitors have revolutionized the treatment of patients with germline B

120 idomide, lenalidomide, and pomalidomide have revolutionized the treatment of patients with multiple m

121 c antigen receptor T-cell therapy (CART) has revolutionized the treatment of patients with refractory

122 ic antigen receptor (CAR) T-cell therapy has revolutionized the treatment of patients with relapsed o

123 nti-tumour necrosis factor (TNF) agents have revolutionized the treatment of patients with rheumatoid

124 atheter aortic valve implantation (TAVI) has revolutionized the treatment of patients with severe aor

125 T tyrosine kinase inhibitor (TKI), imatinib, revolutionized the treatment of patients with this disea

126 Artemisinins have revolutionized the treatment of Plasmodium falciparum ma

127 While oral and topical beta blockers have revolutionized the treatment of proliferating infantile

128 Endothelin receptor antagonists have revolutionized the treatment of pulmonary arterial hyper

129 ic antigen receptor (CAR) T-cell therapy has revolutionized the treatment of relapsed/refractory B-ce

130 uroimmunology over the last two decades have revolutionized the treatment of relapsing forms of multi

131 gh efficacy disease modifying therapies have revolutionized the treatment of relapsing-remitting mult

132 coid therapy by Dr Philip Hench in the 1950s revolutionized the treatment of rheumatic and inflammato

133 ic antigen receptor (CAR) T cell therapy has revolutionized the treatment of several haematological m

134 Monoclonal antibodies (mAbs) have revolutionized the treatment of several human diseases,

135 ry and autoimmune diseases, biologicals have revolutionized the treatment of several immune-mediated

136 ient T cells for adoptive cell therapies has revolutionized the treatment of several types of cancer(

137 h as immune checkpoint inhibitors (ICI) have revolutionized the treatment of solid cancer types, ICI

138 ancer treatment, and targeted therapies have revolutionized the treatment of some cancers.

139 Anti-TNF immunotherapy has revolutionized the treatment of some inflammatory diseas

140 atheter aortic valve implantation (TAVI) has revolutionized the treatment of symptomatic severe aorti

141 against the cell surface antigen, CD20, has revolutionized the treatment of these malignancies.

142 f patients with Parkinson's disease (PD) and revolutionized the treatment of this disorder.

143 2 weeks of daily, well-tolerated therapy has revolutionized the treatment of this insidious disease.

144 Immune checkpoint blockade has revolutionized the treatment of tumors with immunogenic

145 The Fontan procedure has revolutionized the treatment of univentricular hearts.

146 (CAR)-engineered T (CAR-T) cell therapy has revolutionized the treatment of various diseases, includ

147 Autologous CAR T-cell immunotherapies are revolutionizing the treatment of B-cell malignancies.

148 Immunotherapy is revolutionizing the treatment of cancer.

149 (4) Immunotherapy is revolutionizing the treatment of cancer.

150 Targeted therapy is revolutionizing the treatment of cancers, but resistance

151 ascular endothelial growth factor (VEGF) are revolutionizing the treatment of diabetic retinopathy (D

152 Immunotherapy is revolutionizing the treatment of diseases in which dysre

153 sotorasib (AMG510) and adagrasib (MRTX849), revolutionizing the treatment of KRAS(G12C)-dependent lu

154 RNAi-based therapeutics is revolutionizing the treatment of liver diseases, with re

155 cetuximab) and immunotherapeutic agents have revolutionized the treatment options for liver metastase

156 tant implications for fit patients and could revolutionize the treatment paradigm.

157 TCIs have revolutionized the treatment paradigm for non-small-cell

158 f EGFR tyrosine-kinase inhibitors (TKIs) has revolutionized the treatment paradigm for patients with

159 ically immune checkpoint blockade (ICB), has revolutionized the treatment paradigm of triple-negative

160 ell acute lymphoblastic leukemia, which have revolutionized the treatment paradigm, have proven more